DUE DILIGENCE

Venture Capital and Private Equity have vastly different approaches, deal targets and processes.  Scientia understands these discriminating mindsets and brings life science industry expertise, independence and analytical vigor to the painstaking work of vetting prospective investment opportunities.

We leverage our technical, operational and entrepreneur experiences and insight to flesh out the investment thesis by concentrating  on the key issues that will determine the investment’s ultimate success.  As part of the due diligence process, we help clients develop an agenda for creating value once the deal is closed.

Our practice’s co-focus on multinational firms as well as emerging firms gives us a broad understanding of technology innovation, market trends, business models and more.

Our experience and worldwide network of serial innovators and serial entrepreneurs allows us to quickly develop accurate assessments of key industry performance issues, technology development minefields, relevant markets, customer benchmarks and exit options. 

To find out more about Scientia's work in this capability area, please contact us.